• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    More On IMUN

    Quotes

    Charts

    News & Info

    Company

    • Profile
    • Key Statistics
    • SEC Filings
    • Competitors
    • Industry
    • Components

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    Financials

    Immunovative, Inc. (IMUN)

    -Other OTC
    0.14 Down 0.00(3.05%) Jan 30, 3:59PM EST
    Add to Portfolio
    Prev Close:0.14
    Open:0.14
    Bid:N/A
    Ask:N/A
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:0.11 - 0.14
    52wk Range:0.08 - 1.50
    Volume:362,733
    Avg Vol (3m):160,211
    Market Cap:N/A
    P/E (ttm):N/A
    EPS (ttm):-0.09
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMUN

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Immunovative, Inc. focuses on the development and commercialization of the next generation of immunotherapy treatments primarily in the United States. It also has the worldwide exclusive rights to commercialize AlloStim, a patented living cell pro... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback